1-5 of 5
Yang Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B144: Discovery and preclinical evaluation of novel oral WEE1 degraders

Weiqiang Xing, Meixin Tao, Fan Huang, Liuge Gu, Min Cao, Chunhao Wang, Jianxiong Diao, Chunming Du, Xinyu Bai, Mingchen Chen, Xin Zheng, Ying Lei, Yang Xie, Taylor B. Guo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B144.
https://doi.org/10.1158/1535-7163.TARG-23-B144
Published: 01 December 2023
View article titled, Abstract B144: Discovery and preclinical evaluation of novel oral WEE1 degraders
Journal Articles

Abstract B204: A DREAM Challenge to improve prognostic models in patients with metastatic castrate-resistant prostate cancer

Justin Guinney, Tao Wang, Chris Bare, Thea Norman, Brian Bot, Liji Shen, Kimberly Winner, Stephen Friend, Kald Abdallah, Gustavo Stolovitzky, Yang Xie, Fang Liz Zhou, James C. Costello
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B204.
https://doi.org/10.1158/1535-7163.TARG-15-B204
Published: 01 December 2015
View article titled, Abstract B204: A DREAM Challenge to improve prognostic models in patients with metastatic castrate-resistant prostate cancer
Journal Articles

Abstract A24: Targeted synthetic lethal screens to identify acquired vulnerabilities in a novel class of ASCL1-dependent neuroendocrine non-small cell lung cancers

Alexander Augustyn, Mark Borromeo, Tao Wang, Chunli Shao, Patrick Dospoy, Kenneth Huffman, Ryan Carstens, Luc Girard, Carmen Behrens, Ignacio Wistuba, Yang Xie, Jane Johnson, Adi Gazdar, John Minna
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (5_Supplement): A24.
https://doi.org/10.1158/1535-7163.PMS-A24
Published: 01 May 2014
View article titled, Abstract A24: Targeted synthetic lethal screens to identify acquired vulnerabilities in a novel class of ASCL1-dependent neuroendocrine non-small cell lung cancers
Journal Articles

Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

Noriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori, John D. Minna
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (2): 336–346.
https://doi.org/10.1158/1535-7163.MCT-10-0750
Published: 08 February 2011
View article titled, Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
Open the PDF for Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

Reverse-phase protein array (RPPA) profiling of non-small cell lung cancer lines identifies tumor signatures for sensitivity and resistance to chemotherapy and targeted agents

Lauren Averett Byers, Meera Nanjundan, Luc Girard, Kevin Coombes, Yang Xie, Michael Peyton, Yao Ma, Sunny Zachariah, Petros Nikolinakos, Ricardo Cigarroa, Gordon Mills, Jack Roth, John Minna, John Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B178.
Published: 01 November 2007
View article titled, Reverse-phase protein array (RPPA) profiling of non-small cell lung cancer lines identifies tumor signatures for sensitivity and resistance to chemotherapy and targeted agents